Literature DB >> 9362189

Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus.

S K Dutta1, C D Ting, L L Lai.   

Abstract

OBJECTIVES: Patients with the human immunodeficiency virus (HIV) disease can develop pancreatic gland inflammation from HIV infection and related causes, or from factors totally independent of it. The incidence and severity acute pancreatitis in patients with HIV diseases and the frequency of associated etiological factors have not been examined in any detail. The purpose of this study was to (a) determine the prevalence of acute pancreatitis, (b) evaluate severity of pancreatic gland inflammation, (c) identify commonly associated etiological factors with acute pancreatitis, and (d) examine the relationship between CD4 lymphocyte counts and serum pancreatic enzyme levels (amylase and lipase) in patients with HIV disease.
METHODS: We examined the medical records of 321 patients with HIV disease seen at Sinai Hospital of Baltimore between July of 1993 to June of 1994. Data collected from these records included clinical, laboratory, and radiologic features of pancreatitis, staging of HIV disease, risk factors, CD4 lymphocyte counts, medications associated with the presence of opportunistic infections, Kaposi's sarcoma, and lymphoma.
RESULTS: From 321 patients with HIV disease, 45 patients developed at least one episode of acute pancreatitis as defined by clinical and laboratory criteria during the 1-yr period. A statistically significant negative correlation was found between serum pancreatic enzyme level and the number of CD4 lymphocytes (r = -0.15, p < 0.05 for serum amylase; r = -0.2, p < 0.05 for serum lipase). Furthermore, patients with asymptomatic HIV infection or CD4 lymphocyte count >500 mm3 did not develop asymptomatic hyperamylasemia or acute pancreatitis. Furthermore, the presence of gallstones, active injection drug use, pentamidine therapy, Pneumocystis carinii, Mycobacterium avium intracellulare correlated significantly (p < 0.001) with the diagnosis of acute pancreatitis.
CONCLUSIONS: A detailed review of medical records of patients with HIV disease seen in a community hospital in 1 yr (1993-1994) suggests a high incidence (14%) of mild to moderately severe acute pancreatitis. In this group of patients, pancreatic gland inflammation is commonly associated with gallstones, intravenous drug abuse, pentamidine intake, and Pneumocystis carinii and Mycobacterium avium intracellulare infections. In addition, marked reduction in CD4 lymphocyte count is associated with increase in serum pancreatic enzyme levels (amylase, lipase activity) suggesting pancreatic gland inflammation or altered pancreatic enzyme turnover.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362189

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.

Authors:  Ronald B Reisler; Robert L Murphy; Robert R Redfield; Robert A Parker
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

Review 2.  HIV and aging: implications for patient management.

Authors:  Kelly A Gebo
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Temporary Trend, Characteristics and Clinical Outcomes of Acute Pancreatitis Patients Infected with Human Immunodeficiency Virus.

Authors:  Hedong Han; Wei Guo; Honglei Guo; Xin Wei; Xiaochun Xiao; Yiming Ruan; Cheng Wu; Yang Cao; Jia He
Journal:  Dig Dis Sci       Date:  2020-05-28       Impact factor: 3.199

4.  Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis.

Authors:  Vijay P Singh; Gary D Bren; Alicia Algeciras-Schimnich; David Schnepple; Sarah Navina; Stacey A Rizza; Rajinder K Dawra; Ashok K Saluja; Suresh T Chari; Santhi S Vege; Andrew D Badley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-12       Impact factor: 4.052

5.  [Acute pancreatitis].

Authors:  C Wullstein; W O Bechstein
Journal:  Chirurg       Date:  2004-06       Impact factor: 0.955

Review 6.  Acute pancreatitis in HIV/AIDS patients: an issue of concern.

Authors:  Gordana Dragovic
Journal:  Asian Pac J Trop Biomed       Date:  2013-06

7.  Epidemiology of HIV and response to antiretroviral therapy in the middle aged and elderly.

Authors:  Kelly A Gebo
Journal:  Aging health       Date:  2008-12-01

Review 8.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.

Authors:  David J Riedel; Kelly A Gebo; Richard D Moore; Gregory M Lucas
Journal:  AIDS Patient Care STDS       Date:  2008-02       Impact factor: 5.078

10.  JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis.

Authors:  Miho Sekimoto; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Masahiko Hirota; Yasutoshi Kimura; Kazunori Takeda; Shuji Isaji; Masaru Koizumi; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.